April 2024

Blood sample positive for multiple myeloma -- Image credit: angellodeco | stock.adobe.com

Peer Reviewed

Integration of these agents requires supportive care considerations for cytokine release syndrome, neurotoxicity, infection, and antigen-specific toxicities to ensure optimal care of patients with multiple myeloma receiving T-cell–engaging therapies.